← Leaderboards
Lewis R Roberts
Mayo Clinic Coll Of Medicine, Rochester
$8,981,499
Attributed
$16,530,349
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,445,200 · 16
By mechanism
P50$16,707,501 · 3
R01$11,209,254 · 5
U01$2,273,746 · 2
U54$893,453 · 1
K08$493,776 · 1
R21$365,662 · 1
Top collaborators
- Martin Ernesto Fernandez-Zapico12 shared
- Mark A. Mc Niven12 shared
- Christopher I. Amos10 shared
- Manal M Hassan10 shared
- Donghui Li7 shared
- Yi Lin6 shared
- Sean S Park6 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Mark A. Mc Niven$26,441,783
- Mark J Federspiel$5,784,512
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPrimary Carcinoma Of The Liver CellsBaseCollaborationsEarly DiagnosisMalignant Neoplasm Of LiverLiverDiagnosisMolecularMediatingLeadSignal TransductionPathway InteractionsFutureGeneticCessation Of LifeCell DeathInstitutionIncidenceCholangiocarcinomaResourcesSulfatasesHeparin Binding Growth FactorHeparitin Sulfate
Grant awards (81)
Mayo Clinic Hepatobiliary SPORE$2,286,710
P50 · FY2025 · CA
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study$669,307
U01 · FY2025 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$628,467
R01 · FY2025 · CA
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma$610,890
R01 · FY2025 · CA
Career Enhancement Program$285,838
P50 · FY2025 · CA · contact PI
Africa HepatoPancreatoBiliary Cancer Consortium$60,000
R13 · FY2025 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$2,236,005
P50 · FY2024 · CA
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study$636,071
U01 · FY2024 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$612,951
R01 · FY2024 · CA
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma$610,890
R01 · FY2024 · CA
Career Enhancement Program$89,204
P50 · FY2024 · CA · contact PI
Africa Hepatopancreatobiliary Cancer Consortium$30,000
R13 · FY2024 · CA · contact PI
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study$700,243
U01 · FY2023 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$612,054
R01 · FY2023 · CA
Africa Hepatopancreatobiliary Cancer Consortium$30,000
R13 · FY2023 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$2,116,880
P50 · FY2022 · CA
Radiation and dendritic cells to hepatomas to improve immunotherapy response$632,389
R01 · FY2022 · CA
Mayo Clinic Hepatobiliary SPORE$137,617
P50 · FY2022 · CA
Career Enhancement Program$57,323
P50 · FY2022 · CA · contact PI
Africa Hepatopancreatobiliary Cancer Consortium$30,000
R13 · FY2022 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$1,940,707
P50 · FY2021 · CA
Mayo Clinic Hepatobiliary SPORE Diversity Supplement Dr. Musa Gabere$136,012
P50 · FY2021 · CA
Mayo Clinic Hepatobiliary SPORE$109,230
P50 · FY2021 · CA
Career Enhancement Program$73,126
P50 · FY2021 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$2,294,230
P50 · FY2020 · CA
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria$224,944
U54 · FY2020 · CA · contact PI
Career Enhancement Program$90,580
P50 · FY2020 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$2,139,000
P50 · FY2019 · CA
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$602,699
R01 · FY2019 · CA
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria$211,872
U54 · FY2019 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE Project 2 Diversity Supplement Dr. Delwende Aristide Parcouda$109,230
P50 · FY2019 · CA
Mayo Clinic Hepatobiliary SPORE Project 4 Diversity Supplement Dr. Barro Oumar$109,230
P50 · FY2019 · CA
Career Enhancement Program$84,207
P50 · FY2019 · CA · contact PI
Career Enhancement Program$12,136
P50 · FY2019 · CA · contact PI
Career Enhancement Program$12,136
P50 · FY2019 · CA · contact PI
Mayo Clinic Hepatobiliary SPORE$2,300,000
P50 · FY2018 · CA
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$620,205
R01 · FY2018 · CA
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria$209,330
U54 · FY2018 · CA · contact PI
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$165,134
R01 · FY2018 · CA
Career Enhancement Program$88,100
P50 · FY2018 · CA · contact PI
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$655,272
R01 · FY2017 · CA
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria$247,307
U54 · FY2017 · CA · contact PI
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$113,799
R01 · FY2017 · CA
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$657,227
R01 · FY2016 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2016 · CA · contact PI
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)$832,002
R01 · FY2015 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2015 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$13,348
R01 · FY2015 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$317,411
R01 · FY2014 · CA · contact PI
Optimal Long-term Outcome of Chronic Hepatitis B$268,124
U01 · FY2014 · DK · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$93,306
R01 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$93,306
R01 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$51,791
R01 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$307,594
R01 · FY2013 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$67,308
R01 · FY2013 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$44,719
R01 · FY2013 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$40,044
R01 · FY2013 · CA · contact PI
Optimal Long-term Outcome of Chronic Hepatitis B$1
U01 · FY2013 · DK · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2012 · CA · contact PI
Dysregulation of the Tumor Microenvironment in Hepatocellular Carcinoma$199,452
R21 · FY2010 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$272,263
R56 · FY2009 · CA · contact PI
Dysregulation of the Tumor Microenvironment in Hepatocellular Carcinoma$166,210
R21 · FY2009 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$79,545
R56 · FY2009 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$258,035
R01 · FY2008 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$110,337
R01 · FY2008 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$84,616
R01 · FY2008 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$49,975
R01 · FY2008 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$258,035
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$107,383
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$53,137
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$30,924
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$6,808
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$265,742
R01 · FY2006 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$72,635
R01 · FY2006 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$2,861
R01 · FY2006 · CA · contact PI
Molecular Pathogenesis of Hepatocellular Carcinoma$272,138
R01 · FY2005 · CA
Molecular Pathogenesis of Hepatocellular Carcinoma$272,138
R01 · FY2004 · CA
FRA16D CHROMOSOMAL FRAGILE SITE IN LIVER CARCINOGENESIS$123,444
K08 · FY2003 · CA
FRA16D CHROMOSOMAL FRAGILE SITE IN LIVER CARCINOGENESIS$123,444
K08 · FY2002 · CA
FRA16D CHROMOSOMAL FRAGILE SITE IN LIVER CARCINOGENESIS$123,444
K08 · FY2001 · CA
FRA16D CHROMOSOMAL FRAGILE SITE IN LIVER CARCINOGENESIS$123,444
K08 · FY2000 · CA